A COMPARATIVE CLINICAL EVALUATION OF SOME AYURVEDIC DRUGS IN THE TREATMENT OF INFECTIVE HEPATITIS (KAMALA)
Dr. Vipin Kumar*
ABSTRACT
Recent WHO data indicates hepatitis now along with malaria as the fourth most common cause of death from infectious diseases in the world. Among the infectious hepatitis most common are Hepatitis A, B, C, D, E & G are the most hazardous to mankind. Approximately 400 million people get infected with HBV, out of theses more than 50% persons are in south east asian countries. Among these 400 millions approximately 30% die due to complications such as cirrhosis of liver, hepatic encephalopathy & Hepato cellular carcinoma. Liver is concerned with synthetic, excretory as well as metabolic functions. So it is clear that liver has an indispensable and irreplaceable role in the human body. If due to any cause, liver parenchyma gets irreversible damage, all metabolic functions of the body cease and ultimately leads to death. The clinical presentation of Koshtha shakhashrita Kamala and infectious hepatitis (hepatocellular jaundice) seems to be one and the same. Different Ayurvedic preparations have been found to be effective for the treatment of liver disorders. The untiring efforts made by various previous Ayurvedic scholars inspired me to carry out a comparative study on the efficacy of Ayurvedic hepato-protective drugs i.e. Phaltrikadi Kwath, Bhumyamlaki & Amrita swaras.
[Full Text Article] [Download Certificate]